138267 (COM.TO) (TSE:COM) and Biotron (ASX:BIT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for 138267 (COM.TO) and Biotron, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
138267 (COM.TO) | 0 | 0 | 0 | 0 | N/A |
Biotron | 0 | 0 | 0 | 0 | N/A |
Profitability
This table compares 138267 (COM.TO) and Biotron's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
138267 (COM.TO) | N/A | N/A | N/A |
Biotron | N/A | N/A | N/A |
Valuation and Earnings
This table compares 138267 (COM.TO) and Biotron's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
138267 (COM.TO) | N/A | N/A | N/A | N/A | N/A |
Biotron | $853,026.00 | 0.00 | $-4,211,597.95 | A($0.01) | N/A |
138267 (COM.TO) has higher earnings, but lower revenue than Biotron.
Summary
Biotron beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.